ESM1 and endothelial dysfunction: In healthy subjects, low levels of endocan are present, but in pathological endothelium-dependent conditions, the plasma levels increase and can serve as a potential endothelial function marker in endothelial dysfunction pathologies such as cardiovascular diseases: atherosclerosis, hypertension or angiogenic processes such as cancers with vascular endothelial involvement.